Vincent Dioszeghy

Montrouge, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Recent advances in epicutaneous immunotherapy and potential applications in food allergy.

Recent advances in epicutaneous immunotherapy and potential applications in food allergy.

Journal: Frontiers in allergy

Published: September 06, 2023

Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets.

Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets.

Journal: The Journal of allergy and clinical immunology

Published: December 21, 2021

Epicutaneous immunotherapy protects cashew-sensitized mice from anaphylaxis.

Epicutaneous immunotherapy protects cashew-sensitized mice from anaphylaxis.

Journal: Allergy

Published: July 09, 2020

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.

Journal: Frontiers in immunology

Published: May 31, 2018

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice.

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice.

Journal: Allergy

Published: May 08, 2018

Epicutaneous immunotherapy for food allergy as a novel pathway for oral tolerance induction.

Epicutaneous immunotherapy for food allergy as a novel pathway for oral tolerance induction.

Journal: Immunotherapy

Published: November 20, 2015

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.

Journal: Cellular & molecular immunology

Published: October 08, 2015

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

Journal: The Journal of allergy and clinical immunology

Published: February 06, 2014

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: April 22, 2013

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.

Journal: Clinical and translational allergy

Published: July 12, 2012

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

Journal: ISRN allergy

Published: December 19, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026